Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS) Longeveron announces positive Type C meeting with FDA, clarifying regulatory pathway to BLA submission for Lomecel-B for hypoplastic left heart syndrome.

Cardiac surgery instruments Market To Reach USD 2.06 Billion By 2027 | Reports And Data New York, Jan. 28, 2020 (GLOBE NEWSWIRE) -- The Global Cardiac Surgery Instruments Market is forecast to reach USD 2.06 Billion by 2027, according to a new report by Reports and Data. Cardiac...